NYSE:ANVS
Annovis Bio, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.annovisbio.comipo date
Jan 29, 2020
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chroni...Show More
Earnings
Earnings Release in 17 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus